Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Chinese Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Adult-Onset Still's Disease (AOSD)
NCT07706868Phase 4Withdrawn
- Sponsor
- Sobi
- Start
- Sep 2025
- Primary completion
- Sep 2028
01
Overview
A Phase 4 trial of anakinra in systemic juvenile idiopathic arthritis (SJIA), adult-onset Still's disease (AOSD), sponsored by Sobi. Planned start Sep 2025; status: withdrawn.
02
Drugs
anakinra
03
Conditions
systemic juvenile idiopathic arthritis (SJIA)adult-onset Still's disease (AOSD)
Beyond the preview
Go deeper on NCT07706868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07706868.